Bioera SpA
MIL:BIE
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
0.03
0.124
|
Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Bioera SpA
Revenue
Bioera SpA
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
Bioera SpA
MIL:BIE
|
Revenue
€1.6m
|
CAGR 3-Years
-60%
|
CAGR 5-Years
-46%
|
CAGR 10-Years
N/A
|
||
Intercos SpA
MIL:ICOS
|
Revenue
€988.2m
|
CAGR 3-Years
18%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
||
Pharmanutra SpA
MIL:PHN
|
Revenue
€157.8m
|
CAGR 3-Years
20%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
||
Enervit SpA
MIL:ENV
|
Revenue
€90.2m
|
CAGR 3-Years
14%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
Bioera SpA
Glance View
Bioera SpA is a holding company, which engages in the production and sale of organic products, natural cosmetics, and traditional food products. The company is headquartered in Milan, Milano and currently employs 3 full-time employees. The company went IPO on 2005-07-27. The company’s activities are divided into two sectors. The Biological and Natural products sector, through its subsidiaries and affiliated entities, is active in the distribution of natural and organic products; production of organic food from vegetables; manufacture of oil from organic agriculture, and distribution of traditional food products, as well as in the sector of natural origin cosmetics. The Holding sector provides activities of the Company as a parent of the group. The firm controls entities, such as Organic Oils Italia Srl, La Fonte della Vita Srl, KI Group SpA and Organic Food Retail Srl.
See Also
What is Bioera SpA's Revenue?
Revenue
1.6m
EUR
Based on the financial report for Jun 30, 2024, Bioera SpA's Revenue amounts to 1.6m EUR.
What is Bioera SpA's Revenue growth rate?
Revenue CAGR 5Y
-46%
The average annual Revenue growth rates for Bioera SpA have been -60% over the past three years , -46% over the past five years .